DBD vs LIN · P/E 28, rev $3.75B vs P/E 34, rev $33.99B
Diebold Nixdorf, Incorporated (DBD) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
DBD currently screens at market cap $2.82B and trailing P/E 28.1. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the DBD and LIN stock pages for the full models.
Not investment advice.